Cofoe Medical Technology Co

Cofoe Medical Technology Co FCF Yield

The Free Cash Flow Yield of Cofoe Medical Technology Co (301087.SZ) as of Oct 23, 2026 is 4.41 %. In the previous year, Free Cash Flow Yield was 4.62 % — a change of -4.65% (lower).

FCF Yield

4.41 %

YoY

-4.65%

Last updated:

Free Cash Flow Yield of Cofoe Medical Technology Co is 2025 4.41 % . Free Cash Flow Yield of Cofoe Medical Technology Co was 2024 4.62 % . It decreases by -4.65% lower compared to the previous year.

The Cofoe Medical Technology Co FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2018
-0.20 CNY
Jan 1, 2019
-0.41 CNY
Jan 1, 2020
1.04 CNY
Jan 1, 2021
-2.33 CNY
Jan 1, 2022
-4.60 CNY
Jan 1, 2023
0.18 CNY
Jan 1, 2024
4.62 CNY
Jan 1, 2025
4.41 CNY
The Cofoe Medical Technology Co FCF Yield history
YEARFCF YieldYoY
4.41 %-4.65%
4.62 %+2,535.67%
0.18 %-103.81%
-4.60 %+97.94%
-2.33 %-323.62%
1.04 %-354.49%
-0.41 %+105.35%
-0.20 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cofoe Medical Technology Co Stock analysis

What does Cofoe Medical Technology Co do? Cofoe Medical Technology Co., Ltd. generates revenue through the research, development, manufacture, and sale of medical equipment under the Cofoe brand. The company offers products such as blood pressure monitors, infrared thermometers, nursing beds, wheelchairs, nebulizers, moxibustion series, and health protection supplies. These products cater to domestic and overseas markets, serving segments including health monitoring, rehabilitation aids, medical care, traditional Chinese medicine physiotherapy, and respiratory support. The firm's domestic market presence and international sales drive its revenue streams. The company's product portfolio includes health monitoring devices, rehabilitation aids, medical care equipment, traditional Chinese medicine physiotherapy tools, and respiratory support systems. These are sold under the Cofoe brand to both domestic and overseas customers. The firm's focus on traditional Chinese medicine physiotherapy and respiratory support systems differentiates its offerings in the medical equipment sector. Cofoe's domestic market operations and overseas business expansion contribute to its overall revenue. Cofoe Medical Technology Co., Ltd. targets customers seeking health monitoring, rehabilitation, medical care, and traditional Chinese medicine physiotherapy solutions. Its domestic market segment includes hospitals, clinics, and individual consumers, while overseas markets extend to international healthcare providers and consumers. The company's product range, from blood pressure monitors to moxibustion series, supports these segments with specialized medical equipment. Cofoe Medical Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cofoe Medical Technology Co stock

Free Cash Flow Yield of Cofoe Medical Technology Co is 4.41 % in 2025.

Free Cash Flow Yield of Cofoe Medical Technology Co changed from 4.62 % to 4.41 %, representing a -4.65% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Cofoe Medical Technology Co since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Cofoe Medical Technology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Cofoe Medical Technology Co

All Key Metrics — Cofoe Medical Technology Co